Literature DB >> 2928468

Quiescence in 9L cells and correlation with radiosensitivity and PLD repair.

M S Mendonca1, A Rodriguez, E L Alpen.   

Abstract

The onset of quiescence, changes in X-ray sensitivity, and changes in capacity for potentially lethal damage (PLD) repair of unfed plateau-phase 9L44 cell cultures have been systematically investigated. The quiescent plateau phase in 9L cells was the result of nutrient deprivation and was not a cell contact effect. Eighty-five to 90% of the plateau-phase cells had a G1 DNA content and a growth fraction less than or equal to 0.15. The cell kinetic shifts in the population were temporally correlated with a developing radioresistance, which was characterized by a larger shoulder in the survival curve of the quiescent cells (Dq = 5.71 Gy) versus exponentially growing cells (Dq = 4.48 Gy). When the quiescent plateau-phase cells were refed, an increase in radiosensitivity resulted which approached that of exponentially growing 9L cells. Delayed plating experiments after irradiation of exponentially growing cells, quiescent plateau-phase cells, and synchronized early to mid-G1-phase cells indicated that while significant PLD repair was evident in all three populations, the quiescent 9L cells had a higher PLD repair capacity. Although data for immediate plating indicated that 9L cells may enter quiescence in the relatively radioresistant mid-G1 phase, the enhanced PLD repair capacity of quiescent cells cannot be explained by redistribution into G1 phase. When the unfed quiescent plateau-phase 9L cells were stimulated to reenter the cell cycle by replating into fresh medium, the first G1 was extended by 6 h compared with the G1 of exponentially growing or refed plateau-phase 9L cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Year:  1989        PMID: 2928468

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  7 in total

1.  Growth rate, labeling index, and radiation survival of cells grown in the Matrigel thread in vitro tumor model.

Authors:  J J Casciari; L K Chin; J C Livesey; D Boyles; R G Steen; J S Rasey
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-09       Impact factor: 2.416

2.  Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.

Authors:  F M Uckun; W Jaszcz; M Chandan-Langlie; K G Waddick; K Gajl-Peczalska; C W Song
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

3.  Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.

Authors:  Y Okuno; Y Nishimura; I Kashu; K Ono; M Hiraoka
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Haruna Nishimaki; Shinobu Masuda
Journal:  Radiat Oncol       Date:  2017-01-13       Impact factor: 3.481

5.  Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells.

Authors:  Teresa Bernadette Steinbichler; Abdelmoez Alshaimaa; Metzler Veronika Maria; Dejaco Daniel; Riechelmann Herbert; Dudas Jozsef; Skvortsova Ira-Ida
Journal:  Oncotarget       Date:  2017-12-14

6.  RNA sequencing of glioblastoma tissue slice cultures reveals the effects of treatment at the transcriptional level.

Authors:  Susann Haehnel; Michael Rade; Nicole Kaiser; Kristin Reiche; Andreas Horn; Dennis Loeffler; Conny Blumert; Felicitas Rapp; Friedemann Horn; Juergen Meixensberger; Christof Renner; Wolf Mueller; Frank Gaunitz; Ingo Bechmann; Karsten Winter
Journal:  FEBS Open Bio       Date:  2021-12-29       Impact factor: 2.693

7.  In silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroids.

Authors:  Harald Kempf; Haralampos Hatzikirou; Marcus Bleicher; Michael Meyer-Hermann
Journal:  PLoS Comput Biol       Date:  2013-11-14       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.